IFRS 9CoreBanking & Financial Services

Recourse, holdbacks and credit enhancements from originators

IFRS 9 · Financial Instruments

Applies to: Mortgage finance & refinance

In plain words

When a refinance company buys loans, the selling bank may promise to cover some losses. If the bank covers almost all losses, the refinance company has not really bought the loans; it has lent money to the bank. If part of the price is held back to absorb losses, that is money the company owes the bank, recorded separately. Insurance that comes with each loan can reduce the expected loss; a separate promise from the bank usually cannot.

Why it matters

Portfolio purchases rarely transfer all the risk cleanly. Originators commonly give the refinance company recourse for defaulted loans, an obligation to repurchase loans that breach eligibility warranties, a holdback (part of the price withheld and paid later net of losses), first-loss protection, or mortgage insurance attached to the loans. Each feature changes what the buyer has actually acquired. At one extreme, full recourse for credit losses means the originator has kept substantially all the risks and rewards: the originator cannot derecognise the loans, and the buyer does not hold mortgages at all, it holds a receivable from the originator. At the other, a limited holdback is a separate liability of the buyer that absorbs losses. Whether an enhancement is integral to the loans' contractual terms decides whether it reduces ECL or is recognised separately.

Diagnostic questions

Does the originator bear credit losses on the portfolio beyond a small first-loss amount, through recourse, guarantees, swaps or a deferred price, so that it retains substantially all risks and rewards? If so, has the buyer recognised a financing receivable from the originator rather than the mortgage loans? Is part of the purchase price held back, and what are the terms for its release and reduction? Are eligibility warranties and repurchase obligations limited to defects existing at sale (documentation, eligibility) or do they cover later credit performance? Is the credit enhancement (mortgage insurance, borrower-level guarantee, originator first-loss) part of the contractual terms of the loans or a separate contract, and was it transferred with the loans? Is the enhancement provider's own credit risk considered?

Recognition

  1. Analyse the transfer from the originator's side first: if the originator retains substantially all the risks and rewards (for example full recourse for credit losses, or a total return arrangement), the transfer fails derecognition.
  2. In that case the buyer does not recognise the mortgage loans; it recognises a receivable from the originator for the cash paid, measured at amortised cost, with the originator's credit risk (and the mortgages as collateral) driving ECL.
  3. If the originator has transferred substantially all risks and rewards, the buyer recognises the loans (BANK-089).
  4. Holdback: recognise the full loan portfolio and a financial liability to the originator for the amount withheld; when losses reduce the holdback under its terms, reduce the liability, with the credit to profit or loss, while ECL and write-offs on the loans are recognised gross.
  5. Repurchase obligations for breach of eligibility warranties: these give the buyer a right to put defective loans back at par; recognise any claim when a breach is identified and recovery is supported, and consider it in measuring expected losses on the affected loans only if the right is integral to them.
  6. Credit enhancements: include cash flows from collateral and other credit enhancements that are part of the contractual terms of the loans and not recognised separately (for example a mortgage insurance policy that transfers with the loan) in measuring ECL; enhancements that are separate contracts, not integral to the loans, do not reduce ECL and are recognised separately when the buyer has a right to reimbursement.
  7. Reflect the enhancement provider's ability to pay in any amount included.

Measurement

Failed transfer: receivable from originator at the cash paid plus transaction costs, at amortised cost, with ECL driven by the originator's probability of default and the mortgages as collateral. Holdback liability: initially at the amount withheld (discounted if the deferral is long and the effect material); subsequently reduced by losses absorbed and by payments to the originator, with expected changes in the amount payable reflected as revisions to its estimated cash flows. Integral credit enhancements: included in the ECL cash flow estimate, net of the provider's own expected default. Non-integral enhancements: no reduction in ECL; any reimbursement right is recognised as a separate asset under the policy the company has chosen and disclosed.

Presentation & disclosure

Disclose: (1) the nature of credit enhancements, recourse, holdbacks and repurchase rights obtained from originators; (2) the effect of collateral and other credit enhancements on the amounts arising from ECL, and the maximum exposure to credit risk without taking them into account; (3) the carrying amount of holdback liabilities and receivables from originators; (4) significant judgments on whether purchased portfolios are recognised as loans or as financing receivables from originators, and on whether enhancements are integral; (5) concentration of credit risk on individual originators and enhancement providers.

Common mistakes

  • Recognising mortgage loans bought with full recourse to the originator, when the originator has kept substantially all the risks and rewards
  • netting the holdback against the loan balance
  • reducing ECL for an originator guarantee given under a separate agreement that is not integral to the loans
  • ignoring the originator's own credit risk when relying on its recourse
  • treating eligibility repurchase rights as protection against later credit losses
  • recognising the release of a holdback to the originator as an expense instead of settlement of a liability

Simple example

A refinance company buys a portfolio of performing mortgages with principal of SAR 200,000,000 at par. The originator bears no recourse beyond a holdback: 2% of the price (SAR 4,000,000) is withheld for 3 years and reduced by any realised credit losses. The originator's variability analysis shows that the 2% first-loss holdback is small compared with the total variability transferred, including interest rate and prepayment risk, so it has transferred substantially all risks and rewards and the buyer recognises the loans. (A holdback large enough to absorb most expected credit losses could instead mean that the originator has retained substantially all the risks and rewards.)
Journal entry at purchase:
Dr Mortgage loans at amortised cost 200,000,000
Cr Bank 196,000,000
Cr Holdback payable to originator 4,000,000
In year 2 a loan defaults and SAR 600,000 is written off after recovery of the property; under the agreement the holdback is reduced by the same amount.
Dr Loss allowance 600,000
Cr Mortgage loans at amortised cost 600,000
Dr Holdback payable to originator 600,000
Cr Recoveries under originator holdback (P&L, impairment line) 600,000
(ECL on the loans is measured gross. The holdback is a separate liability; the remaining SAR 3,400,000 is paid to the originator at the end of year 3 if no further losses occur.)

Professional judgment

The central judgments are whether the originator has retained substantially all risks and rewards (comparing the buyer's exposure to variability in the portfolio's cash flows before and after the transfer), and whether a credit enhancement is integral to the loans' contractual terms. IFRS 9 does not define 'integral'; relevant factors include whether the enhancement was entered into at the same time as, or in contemplation of, the loans, whether it transfers automatically with the loans, and whether it is documented as part of the loan contract or as a separate agreement between originator and buyer. The accounting for non-integral reimbursement rights is not explicitly addressed by IFRS 9, so the policy must be set and disclosed. These features also need legal analysis of enforceability, especially if the originator becomes insolvent.

Source basis

IFRS 9 · Financial Instruments

Paragraph references

IFRS 9.3.2.6, 3.2.9, 3.2.16–3.2.17IFRS 9.3.2.15IFRS 9.5.5.17IFRS 9.B5.5.55IFRS 9.B3.2.15

Verified against the official standard texts used in the IFRS Expert skill.

IFRS 9 Financial Instruments
Issued: 24 July 2014 · Effective: 1 January 2018

Related issues

Educational and navigation content only. Not professional advice. Does not reproduce official IFRS/IAS text. Consult the authoritative standards and qualified professionals; professional judgment may still be required.